PLASMA LIPOPROTEIN(A) CONCENTRATION IN FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS WITHOUT CORONARY-ARTERY DISEASE

被引:30
作者
GHISELLI, G
GADDI, A
BAROZZI, G
CIARROCCHI, A
DESCOVICH, G
机构
[1] BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030
[2] UNIV BOLOGNA,CTR ARTHEROSCLEROSIS,DEPT GERONTOL,I-40126 BOLOGNA,ITALY
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1992年 / 41卷 / 08期
关键词
D O I
10.1016/0026-0495(92)90163-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial Hypercholesterolemia (FH) is a condition characterized by markedly elevated blood cholesterol, low-density lipoproteins (LDL), and apolipoprotein B-100 (apo B). The molecular basis of this monogenic disease is the defective functioning of the cellular receptor for LDL that recognizes apo B. Lipoprotein(a) [Lp(a)] is a circulating lipoprotein that is structurally related to LDL, as it also contains apo B. To assess the impact of the LDL receptor deficiency on the plasma Lp(a) concentration, we measured Lp(a) in 28 FH patients and in 31 unaffected relatives. Because elevation of Lp(a) concentration in plasma of patients with coronary artery disease (CAD) appears to occur independently from plasma cholesterol levels, to avoid potentially confounding problems, members of the families chosen had no history for the disease. Whereas apo B clearly showed a bimodality of distribution by being significantly higher in the FH patients (166 ± 38 mg/dL) than in the unaffected relatives (92 ± 18 mg/dL), Lp(a) concentration did not differ in the two groups of patients (30 ± 24 mg/dL in the FH patients v 31 ± 23 in the normolipidemic relatives). Similar results were obtained when only siblings were further considered. We conclude that although Lp(a) is closely related to LDL structurally, its level in plasma is not significantly affected by the LDL receptor activity. © 1992.
引用
收藏
页码:833 / 838
页数:6
相关论文
共 34 条
[1]  
ALBERS JJ, 1990, CLIN CHEM, V36, P2019
[2]   EFFECT OF HELP-LDL-APHERESIS ON SERUM CONCENTRATIONS OF HUMAN LIPOPROTEIN(A) - KINETIC-ANALYSIS OF THE POST-TREATMENT RETURN TO BASELINE LEVELS [J].
ARMSTRONG, VW ;
SCHLEEF, J ;
THIERY, J ;
MUCHE, R ;
SCHUFFWERNER, P ;
EISENHAUER, T ;
SEIDEL, D .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1989, 19 (03) :235-240
[3]  
ARMSTRONG VW, 1985, J LIPID RES, V26, P1314
[4]  
Brown M S, 1975, Adv Intern Med, V20, P273
[5]  
CUSHING GL, 1989, ARTERIOSCLEROSIS, V9, P265
[6]   ASSOCIATION OF LEVELS OF LIPOPROTEIN LP(A), PLASMA-LIPIDS, AND OTHER LIPOPROTEINS WITH CORONARY-ARTERY DISEASE DOCUMENTED BY ANGIOGRAPHY [J].
DAHLEN, GH ;
GUYTON, JR ;
ATTAR, M ;
FARMER, JA ;
KAUTZ, JA ;
GOTTO, AM .
CIRCULATION, 1986, 74 (04) :758-765
[7]  
DURRINGTON PN, 1988, LANCET, V1, P1070
[8]  
FLESS GM, 1986, J BIOL CHEM, V261, P8712
[9]   PLASMA LP(A) CONCENTRATION IS INVERSELY CORRELATED WITH THE RATIO OF KRINGLE-IV KRINGLE-V ENCODING DOMAINS IN THE APO(A) GENE [J].
GAVISH, D ;
AZROLAN, N ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :2021-2027
[10]  
GHISELLI G, 1989, HUMAN APOLIPOPROTEIN, V2, P189